NCT05747755 Achieving Diagnostic Excellence Through Prevention and Teamwork
| NCT ID | NCT05747755 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brigham and Women's Hospital |
| Condition | Diagnostic Errors |
| Study Type | INTERVENTIONAL |
| Enrollment | 7,200 participants |
| Start Date | 2023-11-14 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 7,200 participants in total. It began in 2023-11-14 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to link a group of hospitals to measure and share the rates of diagnostic errors, to understand underlying causes of diagnostic errors, and develop ways that hospitals, clinicians, and patients can work together to avoid diagnostic errors and harms due to those errors. The investigators will test how data sharing and collaboration improve diagnostic processes and develop approaches which can be sustained into the future. The approach represents a novel application of rigorous outcome adjudication to the problem of inpatient diagnostic errors using a learning health system model.
Eligibility Criteria
Inclusion Criteria: * Adult patients admitted to general medicine services at one of the participating hospitals and who either died during the hospitalization, were transferred to the ICU \>= 48 hours after admission, or had a rapid response. Exclusion Criteria: * Admitted for a non-medical reason * Patients coded in the field who are moribund on arrival to the hospital
Contact & Investigator
Andrew Auerbach
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT05747755 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diagnostic Errors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05747755 currently recruiting?
Yes, NCT05747755 is actively recruiting participants. Contact the research team at tiffany.lee@ucsf.edu for enrollment information.
Where is the NCT05747755 trial being conducted?
This trial is being conducted at San Francisco, United States, Boston, United States.
Who is sponsoring the NCT05747755 clinical trial?
NCT05747755 is sponsored by Brigham and Women's Hospital. The principal investigator is Andrew Auerbach at University of California, San Francisco. The trial plans to enroll 7,200 participants.